On ECHEMI
Home > Drugs > YANGTZE River Pharmaceutical Group Nanjing Pharmaceutical. Co., Ltd.
YANGTZE River Pharmaceutical Group Nanjing Pharmaceutical. Co., Ltd.
  • Founded in:

    2001-01-16
  • Country:

    China China
  • Address:

    No. 9 Xianlin Avenue, Qixia District, Nanjing
  • Tax NO.:

    91320192726063334T
  • Registered Funds:

    50 million yuan
  • Website:

  • Email:

Related Drugs
Acetylglutamine injection
Main ingredient: acetylglutamine, its chemical name is: N-acetyl-1-glutamine. Molecular formula: C7H12N2O4 Molecular weight: 188.18
Name Description Content CAS NO. Registered Holders
Aceglutamide

After passing through the blood-cerebrospinal fluid barrier, it is decomposed into glutamate and gamma-aminobutyric acid (GABA). Glutamate is involved in the information transmission of the central nervous system. Gamma-aminobutyric acid can antagonize the excitotoxic effects of glutamate, improve nerve cell metabolism, maintain nerve stress resistance, reduce the effect of blood ammonia, and improve brain function.

More

After passing through the blood-cerebrospinal fluid barrier, it is decomposed into glutamate and gamma-aminobutyric acid (GABA). Glutamate is involved in the information transmission of the central nervous system. Gamma-aminobutyric acid can antagonize the excitotoxic effects of glutamate, improve nerve cell metabolism, maintain nerve stress resistance, reduce the effect of blood ammonia, and improve brain function.

2490-97-3 6
Ribavirin Sodium Chloride Injection
The main ingredient of this product is ribavirin, whose chemical name is 1-beta;-D-ribofuranosyl-1,2,4-triazole-3-amide.
Name Description Content CAS NO. Registered Holders
Ribavirin

This product can inhibit the growth of many viruses such as respiratory syncytial virus, influenza virus, hepatitis A virus, adenovirus, etc. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase and mRNA guanosine transferase, thereby causing a decrease in intracellular guanosine triphosphate, damaging viral RNA and protein synthesis, and inhibiting viral replication and transmission. This product may also have an immune effect on respiratory syncytial virus and a neutralizing antibody effect.

More

This product can inhibit the growth of many viruses such as respiratory syncytial virus, influenza virus, hepatitis A virus, adenovirus, etc. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase and mRNA guanosine transferase, thereby causing a decrease in intracellular guanosine triphosphate, damaging viral RNA and protein synthesis, and inhibiting viral replication and transmission. This product may also have an immune effect on respiratory syncytial virus and a neutralizing antibody effect.

36791-04-5 33
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.